Brown Kristina, Anderson Lorraine
Internal Medicine-Pediatrics, University of California Los Angeles, Los Angeles, USA.
Allergy and Immunology, University of California Los Angeles, Los Angeles, USA.
Cureus. 2024 Sep 30;16(9):e70558. doi: 10.7759/cureus.70558. eCollection 2024 Sep.
This case illustrates an example of a patient with mild asthma who experiences a severe life-threatening exacerbation. This patient's experience is one of many that challenges the common misperception that mild, well-controlled asthma is not at risk for severe life-threatening exacerbations. The case exploration highlights the data fueling the new 2019/2020 Global Initiative for Asthma (GINA) guidelines, pharmaco-inequity, and barriers to healthcare access which can increase the risk for poor asthma outcomes. The graphic illustrates when patients with asthma, including those with mild asthma, may benefit from referral to an allergist-immunologist. Overall, this case underscores the importance of bridging the gap between generalists and allergist-immunologists to better serve an oft-overlooked patient population.
该病例展示了一名轻度哮喘患者经历严重危及生命的病情加重的例子。该患者的经历是众多挑战常见误解的案例之一,即轻度、控制良好的哮喘不会有严重危及生命的病情加重风险。病例探究突出了为2019/2020年新版全球哮喘防治创议(GINA)指南提供依据的数据、药物不平等以及医疗保健获取方面的障碍,这些因素会增加哮喘不良结局的风险。该图表说明了哮喘患者,包括轻度哮喘患者,何时可能受益于转诊至过敏症专科医生 - 免疫学家处。总体而言,该病例强调了弥合全科医生与过敏症专科医生 - 免疫学家之间差距以更好地服务于经常被忽视的患者群体的重要性。